Getting European Commission approval ordtak
 Our amended offer addresses all of the outstanding issues raised by Guidant's Board. We have increased the value of our offer, satisfied any perceived antitrust concerns and provided shareholders increased certainty of value by agreeing to pay interest on the $73 share price if the transaction is not closed by the end of the first quarter. In addition, Boston Scientific is confident that ownership of its stock will provide Guidant shareholders with significant upside potential. We strongly encourage the Guidant Board to act in the best interests of Guidant shareholders by declaring our $73 per share offer superior to the revised $67.92 per share transaction with Johnson & Johnson. |
| We expect the current gap between Lycos' closing price and the $97.55 [a share] acquisition [price] to tighten and see few catalysts until the deal closes. |
| The company is taking market share in its major operations and continues to exceed expectations. Our enthusiasm is only tempered by the fact that much of this looks to be in the share price. |
| There is a lot of nervousness about commodity prices and whether they can be sustained at such high levels. There may be some wild swings [in the share price] on the day. |
| It was a good outcome. The share price is probably likely to keep moving upward, so the fact that they were able to get more away at a lower price is probably a good thing. |
| If the deal is done, it won't be for much more than the current price. I don't think anybody's going to pay up to $40 (per share). |
| Management appears to be focused on improving the balance sheet positioning, which appears prudent. We also think the current 5.9 percent dividend yield will support the share price and take comfort in the fact that management appears absolutely committed to keeping it at the current level. |
| substantially in excess of the current share price. |
| If the bid fails, it is likely the share price will fall from current levels. |
| Our amended offer addresses all of the outstanding issues raised by Guidant's Board. We strongly encourage the Guidant Board to act in the best interests of Guidant shareholders by declaring our $73 per share offer superior to the revised $67.92 per share transaction with Johnson & Johnson. |
| There is definitely a takeout premium built into the current stock price. |
| The current share price is 8.50 and the bid is 8.10 ... so I think the chances of that bid happening is probably less than 50/50 anyway despite regulatory or political interference. |
| When J&J lowered the price and came in at $63 a share, it was probably closer to what is the real worth of Guidant. The only thing I can say is this behavior, certainly the behavior of Boston Scientific, is not rational here. I just think they are playing a very dangerous game. |
Antall ordtak er 2099244
varav 2120462 på nordiska
Ordtak (2099244 st) Søk
Kategorier (3944 st) Søk
Forfattere (201333 st) Søk
Bilder (4592 st)
Født (10498 st)
Døde (3319 st)
Datoer (9520 st)
Land (27242 st)
Idiom (4439 st)
Lengde
Topplistor (6 st)
Ordspråksmusik (20 st)
Statistik
Denna sidan visar ordspråk som liknar "Getting European Commission approval is a key step ... but the fact that there has been such a disconnect between the takeout price of $76 (per Guidant share) and the current share price tells you there's more uncertainty and nervousness out there than normal.".
Linkene lenger ned har ikke blitt oversatt till norsk. Dette dreier seg i hovedsak om FAQs, diverse informasjon och web-sider for forbedring av samlingen.
Här har vi samlat ordspråk i 12954 dagar!
Vad är ordtak?
Hur funkar det?
Vanliga frågor
Om samlingen
Ordspråkshjältar
Hjälp till!
varav 2120462 på nordiska
Ordtak (2099244 st) Søk
Kategorier (3944 st) Søk
Forfattere (201333 st) Søk
Bilder (4592 st)
Født (10498 st)
Døde (3319 st)
Datoer (9520 st)
Land (27242 st)
Idiom (4439 st)
Lengde
Topplistor (6 st)
Ordspråksmusik (20 st)
Statistik
Denna sidan visar ordspråk som liknar "Getting European Commission approval is a key step ... but the fact that there has been such a disconnect between the takeout price of $76 (per Guidant share) and the current share price tells you there's more uncertainty and nervousness out there than normal.".
Linkene lenger ned har ikke blitt oversatt till norsk. Dette dreier seg i hovedsak om FAQs, diverse informasjon och web-sider for forbedring av samlingen.
Här har vi samlat ordspråk i 12954 dagar!
Vad är ordtak?
Hur funkar det?
Vanliga frågor
Om samlingen
Ordspråkshjältar
Hjälp till!
 |
Linkene lenger ned har ikke blitt oversatt till norsk. Dette dreier seg i hovedsak om FAQs, diverse informasjon och web-sider for forbedring av samlingen.
Här har vi samlat ordspråk i 12954 dagar!
Vad är ordtak?
Hur funkar det?
Vanliga frågor
Om samlingen
Ordspråkshjältar
Hjälp till!
|